The role of dendritic cells in the induction and regulation of immunity to microbial infection

Current Opinion in Immunology

Volumn 11, Issue 4, 1999, Pages 392-399

  Reis e Sousa, Caetano ^a   Sher, Alan ^b   Kaye, Paul ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; DENDRITIC CELL; HUMAN; IMMUNOTHERAPY; INFECTION; MICROBIAL IMMUNITY; NONHUMAN; PROTOZOAL INFECTION; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 0033178828     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80066-1     Document Type: Article

References (76)

1. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252. References [1••,2••] are general reviews of DC immunobiology.
2. Austyn JM: Dendritic cells. Curr Opin Hematol 1998, 5:3-15. See annotation [1••].
3. Klagge IM, Schneider-Schaulies S: Virus interactions with dendritic cells. J Gen Virol 1999, 80:823-833. A recent review of the role of DCs in antiviral immunity and subversion of DC function by viruses, focusing on HIV and measles virus.
4. Shortman K, Wu L, Suss G, Kronin V, Winkel K, Saunders D, Vremec D: Dendritic cells and T lymphocytes: Developmental and functional interactions. Ciba Found Symp 1997, 204:130-138.
5. Fazekas de St Groth B: The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity. Immunol Today 1998, 19:448-454.
6. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118.
7. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA: Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282:480-483.
8. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
9. + dendritic cells. Immunity 1998, 9:839-847. An intriguing paper showing that the deficiency in DCs previously seen in RelB knockout mice is primarily in the myeloid lineage.
10. Enk AH, Angeloni VL, Udey MC, Katz SI: Inhibition of Langerhans cell antigen-presenting function by IL-10:a role for IL-10 in induction of tolerance. J Immunol 1993, 151:2390-2398.
11. De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M: Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 1997, 27:1229-1235.
12. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML: IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997,159:28-35.
13. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC: Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 1998, 161:5245-5251.
14. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subklewe M, Sauter B, Sheff D et al.: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998, 188:2163-2173. Footpad-immunisation with bone marrow derived DCs allows MHC class II presentation of antigens from the cells in the inoculum by host interdigitating DCs in the popliteal nodes.
15. - DCs can shift the Th2 response towards a Th1 phenotype.
16. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, Maliszewski CR: Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999, 96:1036-1041.
17. Reis e Sousa C, Hieny S, Scharton-Kersten T, Charest H, Jankovic D, Germain RN, Sher A: In vivo microbial stimulation induces rapid CD40l-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J Exp Med 1997, 186:1819-1829.
18. Reis e Sousa C, Germain RN: Analysis of adjuvant function by direct visualization of antigen presentation in vivo: Endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J Immunol 1999, 162:6552-6561.
19. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186. In contrast to the mouse, putative mature lymphoid DCs from humans favour Th2 differentiation of allogeneic naive T cells whereas myeloid (monocyte derived) DCs favour Th1 differentiation. The former DCs are prevented from developing in the presence of prototypical Th2 cytokines (IL-4 and IL-10); this suggests the presence of a negative feedback loop.
20. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med 1999, 189:593-598.
21. Stumbles PA, Thomas JA, Pimm CL, Lee FT, Venaille TJ, Proksch S, Holt PG: Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998, 188:2019-2031.
22. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388:782-787.
23. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, Zimmermann VS, Davoust J, Ricciardi-Castagnoli P: Maturation stages of mouse dendritic cells in growth factor-dependent longterm cultures. J Exp Med 1997, 185:317-328.
24. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M: Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. J Immunol 1997, 158:2919-2925.
25. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi Castagnoli P: Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998, 188:2175-2180. A rare study of signal transduction pathways in DCs. LPS causes maturation of a DC line as well as protecting the cells from apoptosis induced by growth factor withdrawal. Maturation and viability are decreased when degradation of IκB (an inhibitor of NF-κB) and nuclear translocation of NF-κB are prevented. In contrast, an inhibitor of MEK1 (a kinase that activates ERK) does not affect LPS induced maturation but abrogates LPS dependent protection from apoptosis.
26. Janeway CA Jr: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54:1-13.
27. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC: Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998, 161:3042-3049. Bacterial DNA or oligonucleotides containing immunostimulatory CpG motifs activate fetal skin derived DCs - leading to loss of E-cadherin, increases in MHC class II, CD40 and B7 and production of IL-12. Injection of the oligonucleotides into the skin causes activation (increase in MHC class II and B7 levels) of LCs and IL-12 production by some of the cells.
28. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW, Wagner H: Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998, 28:2045-2054.
29. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A: Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999, 189:821-829. This paper demonstrates that influenza infection of DCs promotes maturation, as well as induction of MxA that is dependent on type I IFNs. This effect is mimicked by poly I:C, a synthetic source of dsRNA. The induction of maturation and protection from cytopathic effects of infection may have evolved to ensure T cell priming.
30. + T cell help for CTL responses is shown to be delivered through CD40 mediated activation of APCs. Importantly, infection with influenza activates DCs - bypassing the requirement for CD40 signalling and allowing them to prime CTLs directly.
31. McWilliam AS, Napoli S, Marsh AM, Pemper FL, Nelson DJ, Pimm CL, Stumbles PA, Wells TN, Holt PG: Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 1996, 184:2429-2432.
32. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM: Systemic lipopolysaccharide recruits dendritic cell progenitors to nonlymphoid tissues. Transplantation 1995, 59:1319-1324.
33. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM: Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 1995, 181:2237-2247.
34. MacPherson GG, Jenkins CD, Stein MJ, Edwards C: Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol 1995, 154:1317-1322.
35. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Baetselier P, Urbain J, Leo O, Moser M: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996, 184:1413-1424.
36. Kopp EB, Medzhitov R: The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999, 11:13-18.
37. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J Exp Med 1995, 182:389-400.
38. Condaminet B, Peguet-Navarro J, Stahl PD, Dalbiez-Gauthier C, Schmitt D, Berthier-Vergnes O: Human epidermal langerhans cells express the mannose-fucose binding receptor. Eur J Immunol 1998, 28:3541-3551.
39. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC: The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995, 375:151-155.
40. Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, Mulder AA, van der Heiden AN, Scheidegger D, Oomen LC et al.: Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 1997, 27:2426-2435.
41. - mouse DCs. Oval-bumin in immune complexes is presented much more efficiently than soluble protein by either MHC class II or class I molecules. Presentation by MHC class I involves antigen access to the endogenous pathway. These results indicate that DC receptors can serve a dual function in antigen uptake and delivery to processing compartments and in signalling for DC maturation.
42. Svensson M, Stockinger B, Wick MJ: Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997, 158:4229-4236.
43. Rescigno M, Citterio S, Thery C, Rittig M, Medaglini D, Pozzi G, Amigorena S, Ricciardi-Castagnoli P: Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci USA 1998, 95:5229-5234. Infection of DCs with Streptococcus gordonii induces de novo MHC class I biosynthesis and slightly increases the half-life of class I molecules. Ovalbumin expressed in S. gordonii can be presented to an MHC class I restricted hybridoma following phagocytosis of the bacteria by DCs.
44. PIerre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinman RM, Mellman I: Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997, 388:787-792.
45. Stenger S, Niazi KR, Modlin RL: Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 1998, 161:3582-3588. Infection of human monocyte derived DCs with live M. tuberculosis results in complete downregulation of expression of CD1a, CD1b and CD1c within 48 hours. Downregulation requires a physical interaction between live bacteria and DCs and is selective in that expression of classical MHC molecules is not affected.
46. + cells in lepromatous lesions is due to absence of DCs or to downregulation of CD1 expression (compare with reference [45••]).
47. Henderson RA, Watkins SC, Flynn JL: Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997, 159:635-643.
48. Moll H: Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Immunol Today 1993, 14:383-387.
49. von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC: Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity. J Exp Med 1998, 188:1547-1552. This paper demonstrates important differences between the interactions of DCs with different life cycle stages of Leishmania and suggests that natural infection proceeds sequentially through macrophages and then DCs.
50. Flohe SB, Bauer C, Flohe S, Moll H: Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur J Immunol 1998, 28:3800-3811. DCs pulsed with Leishmania major antigen efficiently protect susceptible BALB/c mice against subsequent challenge with the parasite.
51. Probst P, Skeiky YA, Sleeves M, Gervassi A, Grabstein KH, Reed SG: A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol 1997, 27:2634-2642.
52. Gorak PM, Engwerda CR, Kaye PM: Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 1998, 28:687-695. The first in situ demonstration that DCs are the source of IL-12 in an infectious disease model.
53. Seguin R, Kasper LH: Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii. J Infect Dis 1999, 179:467-474.
54. Kacani L, Frank I, Spruth M, Schwendinger MG, Mullauer B, Sprinzl GM, Steindl F, Dierich MP: Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J Virol 1998, 72:6671-6677.
55. Masurier C, Salomon B, Guettari N, Pioche C, Lachapelle F, Guigon M, Klatzmann D: Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol 1998, 72:7822-7829. HIV administered intravaginally to mice can be subsequently recovered from DCs in draining lymph nodes. Mouse DCs pulsed with HIV ex vivo retain the virus in infectious form and transport it to draining lymph nodes following subcutaneous administration. These observations suggest that DCs may be important for routing infective HIV from peripheral sites to lymph nodes even when the cells are not themselves infected.
56. Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, Pope M, Louder MK, Ehrenberg PK, Parren PW, Burton DR et al.: Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells. J Virol 1998, 72:9788-9794.
57. Fernandez MH, Pitman RJ, Hawrylowicz CM, Rees AD: Dendritic cells from HIV-1-infected patients naturally express HIV-1 gp120 V3 loop-derived peptide ligands. Eur J Immunol 1998, 28:3144-3153.
58. Granelli-Piperno A, Delgado E, Finkel V, Paxton W, Steinman RM: Immature dendritic cells selectively replicate macrophage tropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J Virol 1998, 72:2733-2737. This paper describes how maturation of DCs affects their interaction with macrophage tropic and T cell tropic strains of HIV.
59. Bender A, Albert M, Reddy A, Feldman M, Sauter B, Kaplan G, Hellman W, Bhardwaj N: The distinctive features of influenza virus infection of dendritic cells. Immunobiology 1998, 198:552-567.
60. Hahn G, Jores R, Mocarski ES: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998, 95:3937-3942.
61. Larsson M, Majeed M, Ernst JD, Magnusson KE, Stendahl O, Forsum U: Role of annexins in endocytosis of antigens in immature human dendritic cells. Immunology 1997, 92:501-511.
62. Ojcius DM, Bravo de Alba Y, Kanellopoulos JM, Hawkins RA, Kelly KA, Rank RG, Dautry-Varsat A: Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J Immunol 1998, 160:1297-1303.
63. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD: Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med 1998, 188:809-818. Demonstration that mouse bone marrow derived DCs can phagocytose heat inactivated Chlamydia trachomatis and present Chlamydia antigens to sensitised T cells in vitro. DC interaction with Chlamydia results in production of IL-12 p40. Adoptive transfer of Chlamydia-pulsed DCs confers partial protection to infection of the genital tract with live bacteria.
64. Lu H, Zhong G: Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live chlamydia trachomatis infection. Infect Immun 1999, 67:1763-1769. This paper uses DCs derived from either wild-type or IL-12-p40 knockout mice to demonstrate the importance of this cytokine for DC based vaccination against Chlamydia. Compare with reference [63••].
65. Mbow ML, Zeidner N, Panella N, Titus RG, Piesman J: Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect Immun 1997, 65:3386-3390.
66. Ludewig B, Ehl S, Karrer U, Odermatt B, Hengartner H, Zinkernagel RM: Dendritic cells efficiently induce protective antiviral immunity. J Virol 1998, 72:3812-3818. This paper shows that rapid and long-lasting immunity to LCMV can be obtained by DC based vaccination. CTLs primed by spleen-homing DCs are able to exert their antiviral effects in peripheral sites.
67. Bourguin I, Moser M, Buzoni-Gatel D, Tielemans F, Bout D, Urbain J, Leo O: Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect Immun 1998, 66:4867-4874. Immunisation with DCs pulsed with soluble Toxoplasma antigens elicits partial protection against chronic toxoplasmosis. Protection is associated with both a humoral response and T cell production of IL-2 and IFN-γ.
68. Steinbach F, Borchers K, Ricciardi-Castagnoli P, Ludwig H, Stingl G, Elbe-Burger A: Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity. J Gen Virol 1998, 79:3005-3014.
69. Walker PS, Scharton-Kersten T, Rowton ED, Hengge U, Bouloc A, Udey MC, Vogel JC: Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. Hum Gene Ther 1998, 9:1899-1907.
70. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP: Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 1998, 92:3172-3176.
71. Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, Klinman DM, Hoffman SL: A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 1998, 161:2325-2332.
72. Ahuja SS, Mummidi S, Malech HL, Ahuja SK: Human dendritic cell (DC)-based anti-infective therapy: Engineering DCs to secrete functional IFN-gamma and IL-12. J Immunol 1998, 161:868-876.
73. Shimizu Y, Guidotti LG, Fowler P, Chisari FV: Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998, 161:4520-4529.
74. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999, 5:405-411.
75. Riva S, Nolli ML, Lutz MB, Citterio S, Girolomoni G, Winzler C, Ricciardi-Castagnoli P: Bacteria and bacterial cell wall constituents induce the production of regulatory cytokines in dendritic cell clones. J Inflamm 1996, 46:98-105.
76. Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV: Production of interferon-α/β by murine dendritic cell lines stimulated by virus and bacteria. Scand J Immunol 1997, 46:235-241.